E
GILD icon

Ergoteles’s Gilead Sciences GILD Stock Holding History

Ergoteles’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-7,098
Closed -$547K – 360
2023
Q2 		$547K Sell
7,098
-147,331
-95% -$11.8M 0.03% 620
2023
Q1 		$12.8M Buy
+154,429
New +$12.8M 0.5% 37
2022
Q2 		– Sell
-38,758
Closed -$2.3M – 1777
2022
Q1 		$2.3M Buy
+38,758
New +$2.48M 0.09% 232

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ergoteles's GILD Position: Q3 2023 in Review

Ergoteles sold out of Gilead Sciences (GILD) in Q3 2023, closing a stake of 7,098 shares — an estimated $547K sold.

Ergoteles first reported a position in GILD in Q1 2022 and held it in 3 quarters. The position peaked at $12.8M in Q1 2023. 1,681 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

  • Ergoteles reported no remaining Gilead Sciences position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 7,098 Gilead Sciences shares in Q3 2023, an estimated $547K.
  • Ergoteles first reported a position in Gilead Sciences in Q1 2022 and held it in 3 quarters.
  • Ergoteles's Gilead Sciences position peaked at $12.8M in Q1 2023.
  • 1,681 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.